FOXP1 and systemic lupus erythematosus: Then, MSCs are engineered by overexpressing Foxp1 in order to acquire Foxp1<sup>high</sup> Agg-exo with enhanced immunomodulatory properties, which showes superior therapeutic effect for SLE.